CLINICAL TRIALS PROFILE FOR SOMAVERT
✉ Email this page to a colleague
All Clinical Trials for SOMAVERT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00151437 ↗ | Canadian Pegvisomant Compassionate Study In Acromegalic Patients | Completed | Pfizer | Phase 4 | 2004-11-01 | The purposes of this study are: 1) to provide SOMAVERT for compassionate use to patients with acromegaly or who have completed clinical trials and were responsive, and 2) to evaluate the safety and tolerability of SOMAVERT. |
NCT00476879 ↗ | Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content | Completed | Aarhus University Hospital | N/A | 2006-08-01 | The purpose of this study is to examine the effects of growth hormone during fasting in healthy lean men. |
NCT00476879 ↗ | Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content | Completed | Pfizer | N/A | 2006-08-01 | The purpose of this study is to examine the effects of growth hormone during fasting in healthy lean men. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SOMAVERT
Condition Name
Clinical Trial Locations for SOMAVERT
Trials by Country
Clinical Trial Progress for SOMAVERT
Clinical Trial Phase
Clinical Trial Sponsors for SOMAVERT
Sponsor Name